1 1 Rosebud Healthcare Limited 08849736 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is Health care Services Digita Accounts Production Advanced 6.30.9574.0 true 08849736 2023-04-01 2024-03-31 08849736 2024-03-31 08849736 bus:OrdinaryShareClass1 2024-03-31 08849736 core:RetainedEarningsAccumulatedLosses 2024-03-31 08849736 core:ShareCapital 2024-03-31 08849736 core:FinancialAssetsCostLessImpairment core:Non-currentFinancialInstruments 2024-03-31 08849736 core:CurrentFinancialInstruments 2024-03-31 08849736 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 08849736 core:Non-currentFinancialInstruments 2024-03-31 08849736 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 08849736 core:FurnitureFittingsToolsEquipment 2024-03-31 08849736 bus:SmallEntities 2023-04-01 2024-03-31 08849736 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 08849736 bus:FilletedAccounts 2023-04-01 2024-03-31 08849736 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 08849736 bus:RegisteredOffice 2023-04-01 2024-03-31 08849736 bus:CompanySecretaryDirector1 2023-04-01 2024-03-31 08849736 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 08849736 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 08849736 bus:Agent1 2023-04-01 2024-03-31 08849736 countries:England 2023-04-01 2024-03-31 08849736 2023-03-31 08849736 core:FurnitureFittingsToolsEquipment 2023-03-31 08849736 2022-04-01 2023-03-31 08849736 2023-03-31 08849736 bus:OrdinaryShareClass1 2023-03-31 08849736 core:RetainedEarningsAccumulatedLosses 2023-03-31 08849736 core:ShareCapital 2023-03-31 08849736 core:CurrentFinancialInstruments 2023-03-31 08849736 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 08849736 core:Non-currentFinancialInstruments 2023-03-31 08849736 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 08849736 core:FurnitureFittingsToolsEquipment 2023-03-31 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 08849736

Rosebud Healthcare Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2024

 

Rosebud Healthcare Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 7

 

Rosebud Healthcare Limited

Company Information

Director

Ms June Rosebud Maroveke

Company secretary

Ms June Rosebud Maroveke

Registered office

28 Beecham Road
Reading
RG30 2RD

Accountants

K & N Accounting Ltd 60 Windsor Avenue
London
South West London
SW19 2RR

 

Rosebud Healthcare Limited

(Registration number: 08849736)
Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

19,231

19,231

Other financial assets

5

12,000

12,000

 

31,231

31,231

Current assets

 

Debtors

6

7,247

-

Cash at bank and in hand

 

119

1,084

 

7,366

1,084

Creditors: Amounts falling due within one year

7

(479)

(2,183)

Net current assets/(liabilities)

 

6,887

(1,099)

Total assets less current liabilities

 

38,118

30,132

Creditors: Amounts falling due after more than one year

7

(46,055)

(7,170)

Net (liabilities)/assets

 

(7,937)

22,962

Capital and reserves

 

Called up share capital

8

1

1

Retained earnings

(7,938)

22,961

Shareholders' (deficit)/funds

 

(7,937)

22,962

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 27 March 2025
 

.........................................
Ms June Rosebud Maroveke
Company secretary and director

 

Rosebud Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
28 Beecham Road
Reading
RG30 2RD
England

These financial statements were authorised for issue by the director on 27 March 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Rosebud Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

 

Rosebud Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 April 2023

25,641

25,641

At 31 March 2024

25,641

25,641

Depreciation

At 1 April 2023

6,410

6,410

At 31 March 2024

6,410

6,410

Carrying amount

At 31 March 2024

19,231

19,231

At 31 March 2023

19,231

19,231

5

Other financial assets (current and non-current)

Financial assets at cost less impairment
£

Total
£

Non-current financial assets

Cost or valuation

At 1 April 2023

12,000

12,000

At 31 March 2024

12,000

12,000

Impairment

Carrying amount

At 31 March 2024

12,000

12,000

6

Debtors

7

Creditors

Creditors: amounts falling due within one year

 

Rosebud Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

2024
£

2023
£

Due within one year

Taxation and social security

479

2,183

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

9

46,055

7,170

8

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary of £1 each

1

1

1

1

       

9

Loans and borrowings

Non-current loans and borrowings

2024
£

2023
£

Other borrowings

46,055

7,170

10

Dividends

2024

2023

£

£

Final dividend of £Nil (2023 - £30,000.00) per ordinary share

-

30,000

 

 

11

Related party transactions

 

Rosebud Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Director's remuneration

The director's remuneration for the year was as follows:

2024
£

2023
£

Remuneration

12,570

12,570